Skip to main content
. 2019 Oct 15;11(Suppl 1):S93–S99. doi: 10.1016/j.jcot.2019.10.004

Table 6.

Adjusted models for outcomes and complications by study arm.

Not on Anticoagulants n = 189 Not Reversed n = 84 Reversed n = 186 Model p-value
Total Volume of pRBC Transfused n = 115
 LS Mean (SE)a 581 (58) 511 (106) 743 (54) 0.008
 LS Mean (CI) Differencea −161 (−317, −5) −232 (−470, 6) Reference
 p-difference 0.04 0.06 Reference
Total Volume of Blood Loss n = 443
 LS Mean (SE)b 138 (12) 134 (17) 159 (12) 0.001
 LS Mean (CI) Differenceb −21 (−48, 7) −25 (−62, 12) Reference
 p-difference 0.14 0.18 Reference
Hospital LOS n = 448
 LS Mean (SE)c 6.8 (0.4) 6.3 (0.6) 7.7 (0.4) <0.001
 LS Mean (CI) Differencec −0.9 (−1.6, −0.1) −1.4 (−2.4, −0.3) Reference
 p-difference 0.02 0.01 Reference
ICU LOS n = 57
 LS Mean (SE)d 7.3 (1.8) 6.6 (2.7) 8.5 (1.8) 0.005
 LS Mean (CI) Differenced −1.2 (−5.2, 2.9) −1.9 (−7.5, 3.6) Reference
 p-difference 0.56 0.49 Reference

Bonferroni-adjusted p = 0.025, LS = least-squared mean, SE = standard error, CI = confidence internal, p-difference = p-value for the difference in LS Means, a = adjusted for enrolling facility, b = adjusted for hemiarthroplasty and enrolling facility, c = adjusted for pre-ambulatory status and enrolling facility, d = adjusted for total hip arthroplasty and enrolling facility. Variables available to adjusted models: pre-ambulatory status, pre-operative hemoglobin, pre-operative INR, enrolling facility, pre-injury potassium, pre-injury statins, preinjury analgesics, bipolar hemiarthroplasty, hemiarthroplasty, total hip arthroplasty, internal fixation, and congestive heart failure.